autologous lymphoma cell/allogeneic dendritic cell electrofusion hybrid vaccine
Term · Oncology and biomedicine · MLC-T-ONC-011679
A cell-based cancer vaccine consisting of hybrid cells created by electrofusing allogeneic dendritic cells (DCs) and autologous lymphoma cells with potential immunostimulating and antitumor activities. Upon administration, autologous lymphoma cell/allogeneic dendritic cell electrofusion hybrid vaccine may stimulate the immune system to mount a specific cytotoxic T-lymphocyte (CTL) response against specific autologous lymphoma-associated antigens, resulting in lymphoma cell apoptosis.
| Identifier | MLC-T-ONC-011679 |
|---|---|
| Field | Oncology and biomedicine |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-011679",
"term": "autologous lymphoma cell/allogeneic dendritic cell electrofusion hybrid vaccine",
"field": "Oncology and biomedicine",
"definition": "A cell-based cancer vaccine consisting of hybrid cells created by electrofusing allogeneic dendritic cells (DCs) and autologous lymphoma cells with potential immunostimulating and antitumor activities. Upon administration, autologous lymphoma cell/allogeneic dendritic cell electrofusion hybrid vaccine may stimulate the immune system to mount a specific cytotoxic T-lymphocyte (CTL) response against specific autologous lymphoma-associated antigens, resulting in lymphoma cell apoptosis.",
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/autologous-lymphoma-cell-allogeneic-dendritic-cell-electrofusion-hybrid-vaccine/"
}
Record 3,015 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.